Eduardo Bárcena
Autonomous University of Madrid
6 Papers
Eduardo Bárcena is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Modified Rankin Scale & Stroke. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Futile Interhospital Transfer for Endovascular Treatment in Acute Ischemic Stroke: The Madrid Stroke Network Experience
Blanca Fuentes,María Alonso de Leciñana,Á. Ximénez-Carrillo,Patricia Martínez-Sánchez,A. Cruz-Culebras,Gustavo Zapata-Wainberg,Gerardo Ruiz-Ares,R. Frutos,Eduardo Fandiño,José Luis Caniego,Andrés Fernández-Prieto,Jose C. Méndez,Eduardo Bárcena,Begoña Marín,Andrés García-Pastor,Fernando Díaz-Otero,Antonio Gil-Núñez,Jaime Masjuan,José Vivancos,Exuperio Díez-Tejedor +19 more
TL;DR: Forty-one percent of the ERT transfers were futile, but none of the baseline patient characteristics predicted this result, and Futility could be reduced if repetition of unnecessary diagnostic tests was avoided.
75
Endovascular treatment of intracranial aneurysms using the Pipeline Flex embolization device: a case series of 30 consecutive patients
Mario Martínez-Galdámez,Silvia Pérez,A Vega,P Ruiz,José Luis Caniego,Eduardo Bárcena,P. Saura,Jose C. Méndez,Fernando Delgado,Santiago Ortega-Gutierrez,A Romance,T Diaz,Eva González,Alberto Gil,Eduardo Murias,Pedro Vega +15 more
TL;DR: The new delivery system and the resheathing maneuvers do not seem to increase the intraprocedural complication rate in comparison with the first-generation PED, and the number of devices and the complication rate during the learning curve are lower than reported.
37
Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure
Miriam Saiz-Rodríguez,Daniel Romero-Palacián,Carlos Villalobos-Vilda,José Luis Caniego,Carmen Belmonte,Dora Koller,Eduardo Bárcena,María Talegón,Francisco Abad-Santos,Francisco Abad-Santos +9 more
TL;DR: The antiplatelet response and clinical events after clopidogrel treatment in patients who underwent percutaneous neurointervention, related to CYP2C19 metabolizer status (normal), intermediate/poor (IM‐PM), and ultrarapid (UM); inferred from *2, *3, and *17 allele determination.
Assessment of Collateral Circulation Using Perfusion CT in Middle Cerebral Artery Thrombectomy-Treated Patients.
Santiago Trillo,María Carmen Ramos,Clara Aguirre,José Luis Caniego,Eduardo Bárcena,Saima Bashir,Gustavo Zapata-Wainberg,Pilar Alcántara-Miranda,Carolina Díaz-Pérez,Antonio Barbosa,Rafael Manzanares,Á. Ximénez-Carrillo,Jesús Garrido,Florentino Nombela,José Vivancos +14 more
TL;DR: PATHS had better prognostic value than other scales; therefore, it might be considered for assessment of leptomeningeal collateral circulation in candidates for thrombectomy.
Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.
Miriam Saiz-Rodríguez,Carmen Belmonte,José Luis Caniego,Dora Koller,Pablo Zubiaur,Eduardo Bárcena,Daniel Romero-Palacián,Andy R. Eugene,Dolores Ochoa,Francisco Abad-Santos +9 more
TL;DR: It is confirmed that CYP2C19 is the most important enzyme involved in clopidogrel response, and ABCB1 polymorphisms could be considered for a better pharmacogenetic approach.